Selection from HEOR Bibliography
| Search criteria | ||||
| Poland |
||||
| Patient and caregiver productivity loss and indirect costs associated with cardiovascular events in Europe. | ||||
| Kotseva K1, Gerlier L2, Sidelnikov E3, Kutikova L3, Lamotte M2, Annemans L4, Amarenco P5 | ||||
| 1 Imperial College London, London, United Kingdom 2 IQVIA, Zaventem, Belgium 3 Amgen Europe GmbH, Zug, Switzerland 4 Ghent University, Ghent, Belgium 5 Hospital Bichat-Claude Bernard, Paris, France | ||||
| European Society of Cardiology (ESC) Congress, 2018, Munich, Germany |
||||
| , Poster | ||||
| , Belgium, France, Poland, Portugal, Spain, Switzerland, UK | ||||
| Abstract: https://esc365.escardio.org/Congress/ESC-Congress-2018/Poster-Session-3-Health-economics/176943-patient-and-caregiver-productivity-loss-and-indirect-costs-associated-with-cardiovascular-events-in-europe | ||||
| Condition | Year | Language | Analysis type | |
| , Cardiovascular disease, Health economics | 2018 | English | , Burden of illness, Cost of illness | |
| Regional Differences in Insulin Therapy Regimens in 5 European Countries | ||||
| Rathmann W, Czech M, Franek E, Kostev K | ||||
| Int J Clin Pharmacol Ther. 2017 May;55(5):403-408. |
||||
| , Article | ||||
| , France, Germany, Hungary, Poland, UK | ||||
| Condition | Year | Language | Analysis type | |
| , Diabetes | 2017 | English | ||
| Treatment Persistence of Basal Insulins in Poland and Germany | ||||
| Rathmann W, Czech M, Franek E, Kostev K | ||||
| Int J Clin Pharmacol Ther. 2017 Feb;55(2):119-125. |
||||
| , Article | ||||
| , Germany, Poland | ||||
| Condition | Year | Language | Analysis type | |
| , Diabetes | 2017 | English | ||
| Direct and Indirect Protection with Pediatric Quadrivalent Live-Attenuated Influenza Vaccination in Europe Estimated by a Dynamic Transmission Model | ||||
| Gerlier L1, Hackett J2, Lawson R2, Dos Santos Mendes S3, Weil-Olivier C4, Schwehm M5, Eichner M6,7 | ||||
| 1 QuintilesIMS, Real-World Evidence Solutions, Zaventem, Belgium 2 AstraZeneca, Gaithersburg, MD, USA 3 AstraZeneca, Brussels, Belgium (Current affiliation: MSD, Brussels, Belgium) 4 Department of Pediatrics, University Paris VII, Paris, France 5 ExploSYS GmbH, Leinfelden-Echterdingen, Germany 6 Institute for Clinical Epidemiology and Applied Biometry, University of Tübingen, Tübingen, Germany 7 Epimos GmbH, Dusslingen, Germany | ||||
| JHEOR 2017;5(1):89-108 |
||||
| , Article | ||||
| , Australia, Belgium, Finland, France, Germany, Greece, Italy, Luxembourg, Netherlands, Poland, Portugal, Spain, Sweden, UK | ||||
| Condition | Year | Language | Analysis type | |
| , Immunology and Vaccination, Infectious disease, Respiratory disease | 2017 | English | , Epidemiological study, Public Health | |
| Stage-specific survival and recurrence in patients with cutaneous malignant melanoma in Europe - a systematic review of the literature. | ||||
| Svedman FC1, Pillas D2, Taylor A2, Kaur M2, Linder R3, Hansson J1. | ||||
| 1Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital Solna, Stockholm, Sweden. 2Centre for Observational Research, Amgen Ltd, Uxbridge, UK. 3IMS Health Sweden, Stockholm, Sweden. | ||||
| Clinical Epidemiology |
||||
| , Article | ||||
| , Australia, Austria, Belgium, Bulgaria, Croatia, Czech, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Israel, Italy, Netherlands, Norway, Poland, Portugal, Russian Federation, Serbia and Montenegro, Slovakia, Slovenia, Spain, Sweden, Switzerland, Turkey, UK | ||||
| Abstract: http://www-ncbi-nlm-nih-gov.proxy.kib.ki.se/pmc/articles/PMC4887072/ | ||||
| Condition | Year | Language | Analysis type | |
| , Oncology | 2016 | English | , Literature Review | |
| An International Study of the Ability and Cost-Effectiveness of Advertising Methods to Facilitate Study Participant Self-Enrolment Into a Pilot Pharmacovigilance Study During Early Pregnancy. | ||||
| Richardson JL1, Stephens S1, Thomas SH1, Jamry-Dziurla A2, de Jong-van den Berg L3, Zetstra-van der Woude P3, Laursen M4, Hliva V5, Mt-Isa S6, Bourke A7, Dreyer NA8, Blackburn SC9. | ||||
| 1The UK Teratology Information ServiceNewcastle upon Tyne Hospitals NHS Foundation TrustNewcastle upon TyneUnited Kingdom; Institute of Cellular MedicineNewcastle UniversityNewcastle upon TyneUnited Kingdom. 2Department of Medical Genetics Poznan University of Medical Sciences Poznan Poland. 3Unit of PharmacoEpidemiology and PharmacoEconomics Department of Pharmacy University of Groningen Groningen Netherlands. 4Department of Data Delivery and Medicinal Product Statistics The Danish Health Data Authority Copenhagen Denmark. 5Quintiles Real-World and Late Phase Research St. Prex Switzerland. 6Imperial Clinical Trials Unit School of Public Health Imperial College London London United Kingdom. 7Real World Evidence Solutions IMS Health London United Kingdom. 8Quintiles Real-World & Late Phase Research Cambridge, MA United States. 9Quintiles Real-World and Late Phase Research Reading United Kingdom. | ||||
| , Article | ||||
| , Denmark, Netherlands, Poland, UK | ||||
| Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4869218/pdf/publichealth_v2i1e13.pdf | ||||
| Condition | Year | Language | Analysis type | |
| , Drug safety, Womens Health | 2016 | English | , direct-to-patient research | |
| Rationale and design of a multi-center survey to evaluate productivity losses and indirect costs after cardiovascular events in Europe. | ||||
| Gerlier L1, Sidelnikov E2, Kutikova L2, Lamotte M1, Annemans L3 | ||||
| 1 QuintilesIMS, Zaventem, Belgium 2 Amgen (Europe) GmbH, Zug, Switzerland 3 University of Ghent, Ghent, Belgium | ||||
| 19th ISPOR Annual European Congress, 2016, October 29- November 2, Vienna, Austria |
||||
| , Abstract | ||||
| , Belgium, Czech, France, Germany, Hungary, Italy, Poland, Portugal, Romania, Spain, Switzerland, UK | ||||
| Condition | Year | Language | Analysis type | |
| , Cardiovascular disease | 2016 | English | ||
| Survey on appropriateness of use of nimesulide in nine European countries | ||||
| Franchi S1, Heiman F2, Visentin E2, Sacerdote P1. | ||||
| 1Dipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Milan, Italy. 2Cegedim Strategic Data Medical Research Srl, Milan, Italy. | ||||
| Drug, Healthcare and Patient Safety 2015:7 51-55 |
||||
| , Article | ||||
| , Bulgaria, Czech, Greece, Hungary, Italy, Poland, Portugal, Romania, Slovakia | ||||
| Condition | Year | Language | Analysis type | |
| , Pain | 2015 | English | , Survey research | |
| Economic impact of contrast-induced acute kidney injury associated with invasive cardiology: role of iso-osmolar contrast media in Germany, Italy, Poland and Spain. | ||||
| De Francesco M, Ronco C, Wacinski PJ, Wessely R, Hernández P, Lamotte M. | ||||
| , Germany, Italy, Poland, Spain | ||||
| Abstract: http://dx.doi.org/10.3111/13696998.2015.1105809 | ||||
| Condition | Year | Language | Analysis type | |
| 2015 | English | |||
| Direct-to-Patient Research: Piloting a New Approach to Understanding Drug Safety During Pregnancy | ||||
| Nancy A Dreyer1, MPH, PhD ;Stella CF Blackburn2, MBBS, MA, MSc ; Shahrul Mt-Isa3, BSc, PhD ; Jonathan L Richardson4,5, BBSc (Hons) ; Simon Thomas4,5, BSc, MD, FRCP ; Maja Laursen6, MSc, PhD ; • Priscilla Zetstra-van der Woude7, MSc ; Anna Jamry-Dziurla8, MSc ; Valerie Hliva9, PhD ; Alison Bourke10, BSc, MSc ; Lolkje de Jong-van den Berg7, PharmD, PhD | ||||
| 1Quintiles Real-World & Late Phase Research, Cambridge, MA, United States | ||||
| , Article | ||||
| , Denmark, Netherlands, Poland, UK | ||||
| Condition | Year | Language | Analysis type | |
| , Drug safety, Pregnancy | 2015 | English | , direct-to-patient research, Internet or Interactive voice response system, Prospective study | |
| Direct-to-Patient Research: Piloting a New Approach to Understanding Drug Safety During Pregnancy. | ||||
| Dreyer NA1, Blackburn SC2, Mt-Isa S3, Richardson JL4, Thomas S4, Laursen M5, Zetstra-van der Woude P6, Jamry-Dziurla A7, Hliva V8, Bourke A9, de Jong-van den Berg L6. | ||||
| 1Quintiles Real-World & Late Phase Research Cambridge, MA United States. 2Quintiles Real-World & Late Phase Research Reading United Kingdom. 3Imperial College London United Kingdom. 4Institute of Cellular MedicineNewcastle UniversityNewcastle upon TyneUnited Kingdom; UK Teratology Information ServiceNewcastle HospitalsNHS Foundation TrustNewcastle upon TyneUnited Kingdom. 5Statens Serum Institut Copenhagen Denmark. 6University of Groningen Groningen Netherlands. 7Poznan University of Medical Sciences Poznan Poland. 8Quintiles Real-World & Late-Phase Research St. Prex Switzerland. 9IMS London United Kingdom. | ||||
| JMIR Public Health Surveill. 2015 Dec 22;1(2):e22. |
||||
| , Article | ||||
| , Denmark, Netherlands, Poland, UK | ||||
| Condition | Year | Language | Analysis type | |
| , Drug safety, Womens Health | 2015 | English | , direct-to-patient research | |
| Cost-effectiveness of insulin aspart versus human soluble insulin in type 2 diabetes in four European countries: subgroup analyses from the PREDICTIVE study. | ||||
| Palmer JL1, Goodall G1, Nielsen S3, Kotchie RW,2 Valentine WJ1, Palmer AJ1, Roze S1. | ||||
| 1IMS Health, Basel, Switzerland, 2Novo Nordisk, Bagsværd, Denmark, 3IMS Health, London, UK | ||||
| Curr Med Res Opin. 2008; 24(5):1417-1428 |
||||
| , Manuscript in preparation | ||||
| , Italy, Poland, Spain, Sweden | ||||
| Condition | Year | Language | Analysis type | |
| , Diabetes | 2008 | English | , Cost effectiveness | |
| Mealtime insulin aspart reduces the long-term cost of complications compared to human insulin as part of basal-bolus therapy in Polish type 2 diabetes patients | ||||
| Goodall G1, Nielsen S2, Townsend C2, Kotchie R3, Erny-Albrecht K1, Valentine WJ1 | ||||
| 1 IMS Health, Basel, Switzerland; 2 NovoNordisk, Bagsværd, Denmark; 3 IMS Health, London, UK. | ||||
| ISPOR 2007 10th Annual European Congress, Dublin, Ireland, 20-23 October 2007 |
||||
| , Poster | ||||
| , Poland | ||||
| Condition | Year | Language | Analysis type | |
| , Diabetes | 2007 | English | , Cost effectiveness | |
| Cost-Effectiveness Of Biphasic Insulin Aspart 30 Versus Human Premix Insulin For Type 2 Diabetes Patients In A Polish Setting | ||||
| Aristides M1, Kotchie RW1, Nielsen S2, Townsend C2, Valentine WJ3, Scheijbeler HW1 | ||||
| 1 IMS Health, London, UK; 2 Novo Nordisk A/S, Bagsværd, Denmark; 3 IMS Health, Basel, Switzerland | ||||
| ISPOR 2007 10th Annual European Congress ISPOR 2007 10th Annual European Congress, Dublin, Ireland, 20 - 23 October 2007 |
||||
| , Poster | ||||
| , Poland | ||||
| Condition | Year | Language | Analysis type | |
| , Diabetes | 2007 | English | , Cost effectiveness | |
| Estimating the long-term clinical outcomes associated with switching to insulin aspart (novorapid®) from human soluble insulin in type 2 diabetes patients in the Polish setting | ||||
| Goodall G1, Valentine WJ1, Townsend C2, Kotchie RW3, Nielsen S2, Erny-Albrecht K1 | ||||
| 1 IMS Health, Basel, Switzerland; 2 NovoNordisk, Bagsværd, Denmark; 3 IMS Health, London, UK. | ||||
| ISPOR 2007 10th Annual European Congress, Dublin, Ireland, 20-23 October 2007 |
||||
| , Poster | ||||
| , Poland | ||||
| Condition | Year | Language | Analysis type | |
| , Diabetes | 2007 | English | , Cost utility | |